Ubx-Protein A Fusion Matrix for High-Capacity Antibody Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing antibody purification methods, particularly those using Protein A chromatography, face challenges with high costs, throughput limitations, and ligand leaching, necessitating improved methods to enhance binding capacity and purity.
Innovation Solution
The covalent attachment of multiple immunoglobulin binding domains, such as SpA or Z domain repeats, to Drosophila melanogaster transcription factor Ultrabithorax (Ubx) materials, forming a fusion protein that increases binding capacity and prevents ligand leaching.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional Protein A chromatography is used for antibody purification, then high selectivity (90% purity) is achieved, but the cost is significant and throughput is limited
Solution Approach 1:
The invention segments the Protein A ligand into multiple independent binding domains (E, D, A, B, or C domains) that can be separately expressed and covalently attached to Ubx protein subunits. This segmentation allows each domain to function independently while collectively providing high-capacity purification, resolving the contradiction between maintaining high purity and increasing throughput.
Solution Approach 2:
The invention creates a composite material by fusing Protein A binding domains with Ubx protein, a Drosophila transcription factor known for forming stable filamentous structures. This composite combines the high-affinity binding capability of Protein A with the structural advantages of Ubx, achieving both high purification purity and enhanced productivity through increased ligand capacity.
2Manufacturing precision
If Protein A is crosslinked to solid phase matrices, then antibody purification is achieved, but ligand leaching occurs leading to contamination
Solution Approach 1:
The invention extracts the problematic crosslinking step from the immobilization process. Instead of using chemical crosslinkers that cause ligand leaching, the Protein A binding domains are covalently attached to Ubx proteins through genetic fusion during expression. This eliminates the leaching issue while maintaining stable immobilization on the solid phase matrix.
Solution Approach 2:
The invention uses a genetically encoded fusion protein approach where Protein A domains are permanently integrated into the Ubx structure during expression. This creates a stable, non-leaching ligand system that functions as a permanent fixture on the matrix, eliminating the need for repeated ligand replenishment and ensuring long-term reliability.
3Productivity
If more Protein A ligand is attached to increase binding capacity, then purification capacity increases, but ligand leaching and disassociation increase
Solution Approach 1:
The invention merges multiple Protein A binding domains into a single polypeptide chain fused with Ubx protein. This creates a unified structure where the ligand is an integral part of the support matrix rather than a separate component. The fusion protein approach allows high ligand density while preventing leaching, as the ligand and support are chemically bonded through the fusion peptide.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach results in a 1,000-fold increase in SpA protein per gram of material, enhancing antibody purification capacity and maintaining purity by preventing ligand disassociation from the matrix, even under extreme conditions.
Implementation Method 1
covalent attachment of a protein A domain (E, D, A, B, C) or a synthetic protein Z, for example, a synthetic Z domain, to Drosophila melanogaster transcription factor Ultrabithorax (Ubx) materials
Implementation Method 2
The present disclosure is directed to a composition and methods for increasing the binding capacity of protein A chromatography
Implementation Method 3
Protein A chromatography has been widely recognized as the gold standard for antibody purification due to its high selectivity (90% purity) and capacity
Data Source
AI summary
Provided herein are methods and compositions for purifying antibodies. Purification is achieved by increasing the binding capacity of protein A chromatography by covalent attachment of a protein A domain (E, D, A, B, C), or domain Z, or a functional variant thereof, to Drosophila melanogaster transcription factor Ultrabithorax (Ubx) materials. The compositions include fusion proteins containing Drosophila melanogaster transcription factor Ultrabithorax (Ubx) or a fragment thereof and an immunoglobulin binding protein. In some embodiments, the immunoglobulin binding protein is a protein A domain, a protein Z domain or a fragment thereof.